Horizon Therapeutics Ireland DAC clinical trials
Acquired by Amgen, Oct 6, 2023 · source ↗
The registry lists 1 studies whose lead sponsor is Horizon Therapeutics Ireland DAC. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 7, 2023.
Before and after it joined Amgen
- First submitted before Horizon Therapeutics Ireland DAC became part of Amgen
- 1
- First submitted after Horizon Therapeutics Ireland DAC became part of Amgen
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Horizon Therapeutics Ireland DAC1 study
Something wrong with this grouping? Tell us on the Amgen page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Amgen studies →
- Study to Evaluate HZN-457 in Healthy VolunteersCompletedNCT05565768Phase 1
Sponsor listed in the registry: Horizon Therapeutics Ireland DAC · First submitted before Horizon Therapeutics Ireland DAC became part of Amgen